Jasper Operating Income from 2010 to 2025

JSPRW Stock

USD 0.14 0.01 7.69%

Jasper Therapeutics Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Jasper Therapeutics generates from its operations. View All Fundamentals

Operating Income

First Reported

2020-03-31

Previous Quarter

-19.9 M

Current Value

-25.3 M

Quarterly Volatility

6.4 M

Covid

Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Selling General Administrative of 13.1 M or Other Operating Expenses of 40 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.31. Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Latest Jasper Therapeutics' Operating Income Growth Pattern

Below is the plot of the Operating Income of Jasper Therapeutics over the last few years. Operating Income is the amount of profit realized from Jasper Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Jasper Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Jasper Therapeutics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jasper Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Jasper Operating Income Regression Statistics

	Arithmetic Mean	(23,333,691)
	Geometric Mean	11,385,030
	Coefficient Of Variation	(119.77)
	Mean Deviation	23,610,950
	Median	(4,710,000)
	Standard Deviation	27,947,391
	Sample Variance	781.1T
	Range	71.5M
	R-Value	(0.85)
	Mean Square Error	238.8T
	R-Squared	0.71
	Significance	0.000037
	Slope	(4,962,344)
	Total Sum of Squares	11715.8T

Jasper Operating Income History

	2025	-72.4 M
	2024	-76.2 M
	2023	-68.9 M
	2022	-51.2 M
	2021	-36.8 M
	2020	-20.7 M

Other Fundumenentals of Jasper Therapeutics

Non Operating Income Net Other

Jasper Therapeutics Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Capital Surpluse	Total Liab	Long Term Investments	Total Current Assets	Common Stock	Long Term Debt	Net Receivables	Long Term Debt Total	Net Invested Capital	Capital Stock	Net Working Capital	Current Deferred Revenue	Short Term Debt
Total Assets		0.86	-0.77	-0.98	-0.8	0.98	-0.41	0.78	0.32	0.49	1.0	-0.75	-0.41	-0.78	-0.41	0.98	0.58	1.0	-0.41	0.06
Total Stockholder Equity	0.86		-0.43	-0.86	-0.61	0.75	-0.28	0.42	-0.21	0.37	0.87	-0.34	-0.28	-0.67	-0.28	0.82	0.47	0.83	-0.28	0.07
Net Tangible Assets	-0.77	-0.43		0.76	0.93	-0.85	0.72	-0.89	-0.64	-0.73	-0.74	0.92	0.72	0.68	0.72	-0.84	-0.55	-0.79	0.72	-0.22
Net Debt	-0.98	-0.86	0.76		0.81	-0.95	0.52	-0.69	-0.26	-0.54	-0.99	0.69	0.52	0.8	0.52	-0.94	-0.49	-0.99	0.52	0.07
Retained Earnings	-0.8	-0.61	0.93	0.81		-0.86	0.77	-0.78	-0.37	-0.83	-0.79	0.81	0.77	0.85	0.77	-0.86	-0.4	-0.8	0.77	-0.16
Accounts Payable	0.98	0.75	-0.85	-0.95	-0.86		-0.47	0.87	0.48	0.58	0.97	-0.85	-0.47	-0.82	-0.47	0.97	0.54	0.97	-0.47	0.05
Short Term Investments	-0.41	-0.28	0.72	0.52	0.77	-0.47		-0.34	-0.18	-0.85	-0.41	0.44	1.0	0.55	1.0	-0.46	-0.16	-0.45	1.0	0.1
Capital Surpluse	0.78	0.42	-0.89	-0.69	-0.78	0.87	-0.34		0.74	0.5	0.75	-0.96	-0.34	-0.61	-0.34	0.84	0.63	0.78	-0.34	0.36
Total Liab	0.32	-0.21	-0.64	-0.26	-0.37	0.48	-0.18	0.74		0.21	0.29	-0.8	-0.18	-0.24	-0.18	0.35	0.26	0.36	-0.18	0.03
Long Term Investments	0.49	0.37	-0.73	-0.54	-0.83	0.58	-0.85	0.5	0.21		0.49	-0.49	-0.85	-0.72	-0.85	0.53	0.19	0.48	-0.85	-0.03
Total Current Assets	1.0	0.87	-0.74	-0.99	-0.79	0.97	-0.41	0.75	0.29	0.49		-0.72	-0.41	-0.79	-0.41	0.97	0.55	0.99	-0.41	0.01
Common Stock	-0.75	-0.34	0.92	0.69	0.81	-0.85	0.44	-0.96	-0.8	-0.49	-0.72		0.44	0.65	0.44	-0.8	-0.48	-0.76	0.44	-0.22
Long Term Debt	-0.41	-0.28	0.72	0.52	0.77	-0.47	1.0	-0.34	-0.18	-0.85	-0.41	0.44		0.55	1.0	-0.46	-0.16	-0.45	1.0	0.1
Net Receivables	-0.78	-0.67	0.68	0.8	0.85	-0.82	0.55	-0.61	-0.24	-0.72	-0.79	0.65	0.55		0.55	-0.74	-0.03	-0.75	0.55	0.22
Long Term Debt Total	-0.41	-0.28	0.72	0.52	0.77	-0.47	1.0	-0.34	-0.18	-0.85	-0.41	0.44	1.0	0.55		-0.46	-0.16	-0.45	1.0	0.1
Net Invested Capital	0.98	0.82	-0.84	-0.94	-0.86	0.97	-0.46	0.84	0.35	0.53	0.97	-0.8	-0.46	-0.74	-0.46		0.66	0.97	-0.46	0.24
Capital Stock	0.58	0.47	-0.55	-0.49	-0.4	0.54	-0.16	0.63	0.26	0.19	0.55	-0.48	-0.16	-0.03	-0.16	0.66		0.58	-0.16	0.65
Net Working Capital	1.0	0.83	-0.79	-0.99	-0.8	0.97	-0.45	0.78	0.36	0.48	0.99	-0.76	-0.45	-0.75	-0.45	0.97	0.58		-0.45	0.03
Current Deferred Revenue	-0.41	-0.28	0.72	0.52	0.77	-0.47	1.0	-0.34	-0.18	-0.85	-0.41	0.44	1.0	0.55	1.0	-0.46	-0.16	-0.45		0.1
Short Term Debt	0.06	0.07	-0.22	0.07	-0.16	0.05	0.1	0.36	0.03	-0.03	0.01	-0.22	0.1	0.22	0.1	0.24	0.65	0.03	0.1

Click cells to compare fundamentals

About Jasper Therapeutics Financial Statements

Jasper Therapeutics investors use historical fundamental indicators, such as Jasper Therapeutics' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jasper Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	-76.2 M	-72.4 M
Non Operating Income Net Other	-5 M	-5.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jasper Operating Income from 2010 to 2025

Latest Jasper Therapeutics' Operating Income Growth Pattern

Jasper Operating Income Regression Statistics

Jasper Operating Income History

Other Fundumenentals of Jasper Therapeutics

Jasper Therapeutics Operating Income component correlations

About Jasper Therapeutics Financial Statements

Also Currently Popular

Additional Tools for Jasper Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY